Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy.

Annelise Nicotti GonçalvesAndré M Vieira MessiasLeandro ChavesThaís Marino de Azeredo BastosRodrigo Jorge

Published in: Documenta ophthalmologica. Advances in ophthalmology (2022)

Patients with refractory cCSC treated with intravitreal 50 µg/0.05 ml metoprolol showed no signs of acute ocular toxicity, along with intraretinal fluid reduction and slight BCVA improvement 1 month after injection. This data suggest that intravitreal metoprolol may be a safe alternative for cCSC.

Keyphrases

vascular endothelial growth factor
diabetic retinopathy
age related macular degeneration
optical coherence tomography
liver failure
high grade
oxidative stress
electronic health record
respiratory failure
drug induced
big data
aortic dissection
machine learning
optic nerve
hepatitis b virus